| FIFVX | GAFFX | FIFVX / GAFFX | |
| Total Expense Ratio | 0.79 | 0.29 | 272% |
| Annual Report Gross Expense Ratio | 0.79 | 0.29 | 272% |
| Fund Existence | 8 years | 10 years | - |
| Gain YTD | 5.210 | 9.642 | 54% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 215M | 342B | 0% |
| Annual Yield % from dividends | 0.00 | 0.53 | - |
| Returns for 1 year | 10.90 | 5.98 | 182% |
| Returns for 3 years | 70.93 | 48.97 | 145% |
| Returns for 5 years | 52.78 | 19.03 | 277% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BIB | 122.16 | 3.25 | +2.74% |
| ProShares Ultra Nasdaq Biotechnology | |||
| BREE | 27.17 | 0.24 | +0.88% |
| MFS Blended Research Em Mkts Eq ETF | |||
| ESUM | 31.10 | 0.12 | +0.39% |
| Eventide Us Market ETF | |||
| HIX | 3.94 | 0.01 | +0.25% |
| Western Asset High Income Fund II | |||
| RWR | 114.42 | -0.05 | -0.04% |
| State Street® SPDR® Dow Jones® REIT ETF | |||